Toggle light / dark theme

Estonia To Offer Free Genetic Testing, And Other Nations May Follow

The initiative, which launched on March 20, will start by providing 100,000 of its 1.3 million residents with information on their genetic risk for certain diseases. Genetic information from the project will first be delivered to a family doctor, so that patients will receive counseling about what their results actually mean and how they can better adapt their lifestyle to avoid illness.


The nation of Estonia is establishing a program that provides both free genetic testing and health advice to all citizens based on their results.

Transhumanism: advances in technology could already put evolution into hyperdrive – but should they?

Advocates of transhumanism face a similar choice today. One option is to take advantage of the advances in nanotechnologies, genetic engineering and other medical sciences to enhance the biological and mental functioning of human beings (never to go back). The other is to legislate to prevent these artificial changes from becoming an entrenched part of humanity, with all the implied coercive bio-medicine that would entail for the species.


We can either take advantage of advances in technology to enhance human beings (never to go back), or we can legislate to prevent this from happening.

Steve Horvath – Aging and the Epigenetic Clocks

Today we bring you an interview with Professor Steve Horvath pioneer of the epigenetic clocks of aging.

Steve Horvath is a Professor of Human Genetics and Biostatistics at UCLA. His research sits at the intersection of biostatistics, bioinformatics, computational biology, cancer research, genetics, epidemiology, epigenomics, machine learning, and systems biology.

Genetic switch activates transformation of stem cells into heart muscle cells

The discovery of a genetic switch that triggers stem cells to turn into heart cells is a major step in finding treatment for damaged hearts.

Researchers from A*STAR and their colleagues in India have been investigating the molecular and genetic processes by which human embryonic differentiate into the body’s many types of cells—in particular, cardiomyocytes, or .

“The effort is underway globally to find ways to differentiate these stem cells into beating functional heart muscle cells so that they can be used for cell-based therapies to treat structural abnormalities,” says Prabha Sampath, from the A*STAR Institute of Medical Biology.

Nanospears deliver genetic material to cells with pinpoint accuracy

UCLA scientists have developed a new method that utilizes microscopic splinter-like structures called “nanospears” for the targeted delivery of biomolecules such as genes straight to patient cells. These magnetically guided nanostructures could enable gene therapies that are safer, faster and more cost-effective.

The research was published in the journal ACS Nano by senior author Paul Weiss, UC Presidential Chair and distinguished professor of chemistry and biochemistry, materials science and engineering, and member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA.

Gene therapy, the process of adding or replacing missing or defective genes in patient cells, has shown great promise as a treatment for a host of diseases, including hemophilia, muscular dystrophy, immune deficiencies and certain types of cancer.

/* */